Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ASH2L pseudogene 4 (ASH2LP4) is a pseudogene, a DNA sequence similar to the ASH2L gene but generally considered non-functional because it does not code for an active protein. Unlike the functional ASH2L gene (Absent, small, or homeotic discs-like protein 2), which encodes a core component of MLL family histone methyltransferases important for chromatin regulation and cell proliferation[1][2][3], ASH2LP4 lacks coding potential and is not characterized as a therapeutic molecular target. ASH2LP4 has no documented role in biological function, disease association, molecular interaction, or relevance as a drug target. Relevant context: - The functional ASH2L gene is a protein-coding gene involved in histone methylation, cell proliferation, and transcription regulation and has disease relevance in cancer, especially leukemia[2][3][4]. - Pseudogenes like ASH2LP4 are typically not expressed as proteins and are not regarded as drug targets or functional molecular entities in therapeutics or diagnostics. There is no evidence in current biomedical databases or the literature that ASH2LP4 should be considered a receptor, enzyme, transporter, transcription factor, or other therapeutic target. If you intended to refer to functional ASH2L (and not the pseudogene), please clarify, as ASH2L itself is biologically and clinically relevant[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ASH2L pseudogene 4 (ASH2LP4).